Eli Lilly and Company (NYSE:LLY – Free Report) had its price target hoisted by Citigroup from $1,060.00 to $1,250.00 in a research note issued to investors on Friday morning, Benzinga reports.
The global injection pen market is expanding at a fast rate with the growing prevalence of chronic diseases, and increasing demand for convenient self-administration options. This trend is a move ...